Baseline Characteristics of Participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial
- 31 January 2009
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 53 (1), 121-128
- https://doi.org/10.1053/j.ajkd.2008.08.010
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Expressing the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate with Standardized Serum Creatinine ValuesClinical Chemistry, 2007
- Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trialAmerican Heart Journal, 2006
- Homocysteine Lowering with Folic Acid and B Vitamins in Vascular DiseaseNew England Journal of Medicine, 2006
- Homocysteine Lowering and Cardiovascular Events after Acute Myocardial InfarctionNew England Journal of Medicine, 2006
- Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure: A Multicenter, Randomized, Controlled TrialJournal of the American College of Cardiology, 2006
- Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk FactorsACC Current Journal Review, 2005
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2005
- Cardiovascular Mortality Risk in Chronic Kidney DiseaseJama-Journal Of The American Medical Association, 2005
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Creatinine assay by a reaction-kinetic principleClinica Chimica Acta; International Journal of Clinical Chemistry, 1972